Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",leukocyte quantity,,RS:0000714,WKY/N,both,139 days to 132 days,208,,CMO:0000027,white blood cell count,,,,4.7,x 1000 cells/ul,0.0555,0.8,MMO:0000144,automated total white blood cell count test,,0,,,,,naive control condition,65941,naive control condition 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",platelet quantity,,RS:0000714,WKY/N,both,139 days to 132 days,208,,CMO:0000029,platelet count,,,,741,x 1000 cells/ul,4.1603,60.0,MMO:0000146,automated blood cell counting method,,0,,,,,naive control condition,65929,naive control condition 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",erythrocyte quantity,,RS:0000714,WKY/N,both,139 days to 132 days,208,,CMO:0000025,red blood cell count,,,,8.89,x 10E6 cells/ul,0.0444,0.64,MMO:0000146,automated blood cell counting method,,0,,,,,naive control condition,65935,naive control condition 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",blood hemoglobin amount,,RS:0000714,WKY/N,both,139 days to 132 days,208,,CMO:0000026,blood hemoglobin level,,,,16.1,g/dl,0.0832,1.2,MMO:0000146,automated blood cell counting method,,0,,,,,naive control condition,65917,naive control condition 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",erythrocyte size trait,,RS:0000714,WKY/N,both,139 days to 132 days,208,,CMO:0000038,mean corpuscular volume,,,,63.3,fl,0.0555,0.8,MMO:0000146,automated blood cell counting method,,0,,,,,naive control condition,65923,naive control condition 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",kidney mass,,RS:0000714,WKY/N,male,182 days to 126 days,N/A,,CMO:0000340,both kidneys wet weight to body weight ratio,,,,6.1,g/kg,0.4,,MMO:0000005,post excision weight measurement,kidney,0.0,,,,,control condition (between 42 and 77 days),107533,control condition (between 42 and 77 days) 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",arterial blood pressure trait,,RS:0000714,WKY/N,female,84 days,22,,CMO:0000009,mean arterial blood pressure,,,,117,mmHg,5.0,23.4521,MMO:0000013,vascular fluid filled catheter,right carotid,,,,,,naive control condition,13069,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",arterial blood pressure trait,,RS:0000714,WKY/N,male,84 days,15,,CMO:0000009,mean arterial blood pressure,,,,110,mmHg,8.0,30.9839,MMO:0000013,vascular fluid filled catheter,right carotid,,,,,,naive control condition,13061,naive control condition 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",kidney mass,,RS:0000714,WKY/N,male,182 days to 126 days,N/A,,CMO:0000081,kidney weight,,,,2.18,g,0.08,,MMO:0000005,post excision weight measurement,kidney,0.0,,,,,control condition (between 42 and 77 days),107529,control condition (between 42 and 77 days) 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",heart left ventricle mass,,RS:0000714,WKY/N,female,84 days,22,,CMO:0000071,heart left ventricle wet weight,,,,0.592,g,0.052,0.2439,MMO:0000005,post excision weight measurement,,,,,,,naive control condition,13072,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",heart left ventricle mass,,RS:0000714,WKY/N,male,84 days,15,,CMO:0000071,heart left ventricle wet weight,,,,0.793,g,0.043,0.1665,MMO:0000005,post excision weight measurement,,,,,,,naive control condition,13064,naive control condition 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",erythrocyte quantity,,RS:0000714,WKY/N,both,139 days to 132 days,208,,CMO:0000037,hematocrit,,,,56.3,%,0.3051,4.4,MMO:0000146,automated blood cell counting method,,0,,,,,naive control condition,65911,naive control condition 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",blood glucose amount,,RS:0000714,WKY/N,both,125 days to 118 days,220,,CMO:0000046,blood glucose level,,,,221.4,mg/dl,3.3737,50.04,MMO:0000164,intraperitoneal glucose tolerance test,,0,,glucose injection,120,min,glucose solution (2 g/kg) ,65982,glucose solution (2 g/kg) 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",blood glucose amount,,RS:0000714,WKY/N,both,125 days to 118 days,220,,CMO:0000046,blood glucose level,,,,406.8,mg/dl,4.6722,69.3,MMO:0000164,intraperitoneal glucose tolerance test,,0,,glucose injection,30,min,glucose solution (2 g/kg) ,65976,glucose solution (2 g/kg) 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",blood glucose amount,,RS:0000714,WKY/N,both,125 days to 118 days,220,,CMO:0000046,blood glucose level,,,,138.24,mg/dl,0.7888,11.7,MMO:0000164,intraperitoneal glucose tolerance test,,0,,glucose injection,0,min,glucose solution (2 g/kg) ,65946,glucose solution (2 g/kg) 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",heart mass,,RS:0000714,WKY/N,both,174 days to 167 days,45,,CMO:0000074,heart weight to body weight ratio,,,,3.96,g/kg,0.0373,0.25,MMO:0000005,post excision weight measurement,,0,,,,,naive control condition,66000,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",heart mass,,RS:0000714,WKY/N,female,84 days,22,,CMO:0000074,heart weight to body weight ratio,,,,2.55,g/kg,0.24,1.1257,MMO:0000005,post excision weight measurement,,,,,,,naive control condition,13073,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",heart mass,,RS:0000714,WKY/N,male,84 days,15,,CMO:0000074,heart weight to body weight ratio,,,,2.99,g/kg,0.08,0.3098,MMO:0000005,post excision weight measurement,,,,,,,naive control condition,13065,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",heart left ventricle mass,,RS:0000714,WKY/N,female,84 days,22,,CMO:0000530,heart left ventricle weight to body weight ratio,,,,1.68,mg/g,0.14,0.6567,MMO:0000005,post excision weight measurement,,,,,,,naive control condition,13074,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",heart left ventricle mass,,RS:0000714,WKY/N,male,84 days,15,,CMO:0000530,heart left ventricle weight to body weight ratio,,,,1.99,mg/g,0.08,0.3098,MMO:0000005,post excision weight measurement,,,,,,,naive control condition,13066,naive control condition 3094,"Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005.",arterial blood pressure trait,,RS:0000714,WKY/N,both,270 days to 180 days,9,,CMO:0000004,systolic blood pressure,,,,109,mmHg,7.0,21.0,MMO:0000031,tail cuff plethysmography,,0.0,,,,,naive control condition,107636,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",arterial blood pressure trait,,RS:0000714,WKY/N,female,84 days,22,,CMO:0000004,systolic blood pressure,,,,130,mmHg,5.0,23.4521,MMO:0000013,vascular fluid filled catheter,right carotid,,,,,,naive control condition,13067,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",arterial blood pressure trait,,RS:0000714,WKY/N,male,84 days,15,,CMO:0000004,systolic blood pressure,,,,129,mmHg,8.0,30.9839,MMO:0000013,vascular fluid filled catheter,right carotid,,,,,,naive control condition,13059,naive control condition 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",arterial blood pressure trait,,RS:0000714,WKY/N,both,132 days to 125 days,220,,CMO:0000004,systolic blood pressure,,,,143,mmHg,0.7416,11.0,MMO:0000053,tail cuff piezoplethysmography,,,6-8 readings per sitting,,,,naive control condition,11672,naive control condition 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",adrenal gland mass,,RS:0000714,WKY/N,both,174 days to 167 days,210,,CMO:0000164,both adrenal glands wet weight,,,,45.7,mg,0.3174,4.6,MMO:0000005,post excision weight measurement,,0,,,,,naive control condition,65988,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",arterial blood pressure trait,,RS:0000714,WKY/N,female,84 days,22,,CMO:0000005,diastolic blood pressure,,,,103,mmHg,9.0,42.2137,MMO:0000013,vascular fluid filled catheter,right carotid,,,,,,naive control condition,13068,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",arterial blood pressure trait,,RS:0000714,WKY/N,male,84 days,15,,CMO:0000005,diastolic blood pressure,,,,91,mmHg,8.0,30.9839,MMO:0000013,vascular fluid filled catheter,right carotid,,,,,,naive control condition,13060,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",heart mass,,RS:0000714,WKY/N,female,84 days,22,,CMO:0000069,heart wet weight,,,,0.899,g,0.07,0.3283,MMO:0000005,post excision weight measurement,,,,,,,naive control condition,13071,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",heart mass,,RS:0000714,WKY/N,male,84 days,15,,CMO:0000069,heart wet weight,,,,1.195,g,0.054,0.2091,MMO:0000005,post excision weight measurement,,,,,,,naive control condition,13063,naive control condition 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",body mass,,RS:0000714,WKY/N,both,70 days,220,,CMO:0000012,body weight,,,,215,g,1.3551,20.1,MMO:0000016,body weighing method,,0,,,,,naive control condition,66008,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",body mass,,RS:0000714,WKY/N,female,84 days,22,,CMO:0000012,body weight,,,,353,g,19.0,89.1179,MMO:0000016,body weighing method,,,,,,,naive control condition,13070,naive control condition 327,"Ye P and West MJ, Clin Exp Pharmacol Physiol 2003 Dec;30(12):930-6.",body mass,,RS:0000714,WKY/N,male,84 days,15,,CMO:0000012,body weight,,,,399,g,16.0,61.9677,MMO:0000016,body weighing method,,,,,,,naive control condition,13062,naive control condition 114,"Johannesson M, et al., Genome Res. 2009 Jan;19(1):150-8",adrenal gland mass,,RS:0000714,WKY/N,both,174 days to 167 days,210,,CMO:0000621,both adrenal glands weight to body weight ratio,,,,21.6,mg/100g,0.2346,3.4,MMO:0000005,post excision weight measurement,,0,,,,,naive control condition,65994,naive control condition 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",body mass,,RS:0000714,WKY/N,male,147 days to 126 days,N/A,,CMO:0000012,body weight,,,,309,g,8.0,,MMO:0000016,body weighing method,,0.0,,,,,control condition (for 42 days),107525,control condition (for 42 days) 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",urine protein amount,,RS:0000714,WKY/N,male,224 days to 210 days,N/A,,CMO:0000759,urine protein excretion rate,,,,18,mg/d,2.0,,MMO:0000334,urine protein analysis,,86400.0,metabolic cage; sulfosalicylic acid method,,,,control condition,107471,control condition 3094,"Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005.",ion homeostasis trait,,RS:0000714,WKY/N,both,270 days to 180 days,9,,CMO:0003497,net potassium efflux to blood lymphocyte dry weight ratio per unit time,,,,7.38,mmol/kg/h,2.3,6.9,MMO:0000729,flame photometry,,0.0,,,,,naive control condition,107642,naive control condition 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000714,WKY/N,male,224 days to 210 days,N/A,,CMO:0003443,kidney tubule regeneration foci count,,foci of tubular regeneration,,0.5,/section,0.4,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107483,control condition 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",kidney integrity trait,,RS:0000714,WKY/N,male,182 days to 126 days,N/A,,CMO:0003443,kidney tubule regeneration foci count,,,,0.25,/section,0.25,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107545,control condition 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000714,WKY/N,male,224 days to 210 days,N/A,,CMO:0003445,interstitial nephritis foci count,,foci of interstitial nephritis,,0.9,/section,0.4,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107487,control condition 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",kidney integrity trait,,RS:0000714,WKY/N,male,182 days to 126 days,N/A,,CMO:0003445,interstitial nephritis foci count,,,,0.5,/section,0.3,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107549,control condition 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000714,WKY/N,male,224 days to 210 days,N/A,,CMO:0003444,kidney total tubule cast count,,total tubular casts,,0.6,/section,0.3,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107491,control condition 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",kidney integrity trait,,RS:0000714,WKY/N,male,182 days to 126 days,N/A,,CMO:0003444,kidney total tubule cast count,,,,1,/section,1.0,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107553,control condition 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney integrity trait,,RS:0000714,WKY/N,male,224 days to 210 days,N/A,,CMO:0003446,renal fibrosis foci count,,foci of renal fibrosis,,16,/section,1.0,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107495,control condition 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",kidney integrity trait,,RS:0000714,WKY/N,male,182 days to 126 days,N/A,,CMO:0003446,renal fibrosis foci count,,,,5.9,/section,0.7,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107557,control condition 3094,"Furspan PB, etal., J Hypertens. 1987 Jun;5(3):293-7. doi: 10.1097/00004872-198706000-00005.",ion homeostasis trait,,RS:0000714,WKY/N,both,270 days to 180 days,11,,CMO:0003496,net sodium influx to blood lymphocyte dry weight ratio per unit time,,,,5.12,mmol/kg/h,2.6,8.6232,MMO:0000729,flame photometry,,0.0,,,,,naive control condition,107640,naive control condition 3088,"Wong VY, etal., Br J Pharmacol. 2001 Nov;134(5):977-84. doi: 10.1038/sj.bjp.0704329.",kidney glomerulus integrity trait,,RS:0000714,WKY/N,male,224 days to 210 days,N/A,,CMO:0003447,kidney glomerular lesion count,,,,0.5,/section,0.4,,MMO:0000561,ex vivo light microscopy with histochemistry,,0.0,,,,,control condition,107475,control condition 3090,"Abrahamsen CT, etal., J Pharmacol Exp Ther. 2002 Apr;301(1):21-8. doi: 10.1124/jpet.301.1.21.",kidney glomerulus integrity trait,,RS:0000714,WKY/N,male,182 days to 126 days,N/A,,CMO:0003447,kidney glomerular lesion count,,,,0.8,/section,0.5,,MMO:0000561,ex vivo light microscopy with histochemistry,renal glomerulus,0.0,,,,,control condition,107537,control condition